Book Chapter
Rajandram, Retnagowri, Ong, Teng Aik and Saad, Marniza (2014). Resistance of renal cell carcinoma to targeted therapy. Advances in drug resistance research. (pp. 203-223) edited by Christudas Morais. Hauppage, NY United States: Nova Science Publishers.
Journal Articles
Perumal, Komathi, Mun, Kein Seong, Yap, Ning Yi, Razack, Azad Hassan Abdul, Gobe, Glenda Carolyn, Ong, Teng Aik, Kuppusamy, Shanggar and Rajandram, Retnagowri (2020). A study on the immunohistochemical expressions of leptin and leptin receptor in clear cell renal cell carcinoma. BioMed Research International, 2020 3682086, 1-10. doi: 10.1155/2020/3682086
Perumal, Komathi, Kit Huin, Weng, Yi Yap, Ning, Aik Ong, Teng, Carolyn Gobe, Glenda and Rajandram, Retnagowri (2019). Corrigendum to “Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis” (Medical Hypotheses (2019) 129, (S0306987719301100), (10.1016/j.mehy.2019.109239)). Medical Hypotheses, 131 109284, 109284. doi: 10.1016/j.mehy.2019.109284
Perumal, Komathi, Huin, Weng Kit, Yap, Ning Yi, Ong, Teng Aik, Gobe, Glenda Carolyn and Rajandram, Retnagowri (2019). Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis. Medical Hypotheses, 129 109239, 109239. doi: 10.1016/j.mehy.2019.109239
Ng, Keng Lim, Yap, Ning Yi, Rajandram, Retnagowri, Small, David, Pailoor, Jayalakshmi, Ong, Teng Aik, Razack, Azad Hassan, Wood, Simon Thomas, Morais, Christudas and Gobe, Glenda Carolyn (2018). Nuclear factor-kappa B subunits and their prognostic cancer-specific survival value in renal cell carcinoma patients. Pathology, 50 (5), 511-518. doi: 10.1016/j.pathol.2018.03.003
Gobe, Glenda C., Ng, Keng Lim, Small, David M., Vesey, David A., Johnson, David W., Samaratunga, Hemamali, Oliver, Kimberley, Wood, Simon, Barclay, Johanna L., Rajandram, Retnagowri, Li, Li and Morais, Christudas (2016). Decreased apoptosis repressor with caspase recruitment domain confers resistance to sunitinib in renal cell carcinoma through alternate angiogenesis pathways. Biochemical and Biophysical Research Communications, 473 (1), 47-53. doi: 10.1016/j.bbrc.2016.03.048
Rajandram, Retnagowri, Razack, Azad H. A., Ng, Keng Lim and Gobe, Glenda C. (2016). Decreased expression of inhibitor of caspase-activated DNase (ICAD) in renal cell carcinoma - tissue microarray of human samples. Journal of Kidney Cancer and VHL, 3 (1), 1-11. doi: 10.15586/jkcvhl.2016.47
Yap, Ning Yi, Rajandram, Retnagowri, Ng, Keng Lim, Pailoor, Jayalakshmi, Fadzli, Ahmad and Gobe, Glenda Carolyn (2015). Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms. BioMed Research International, 2015 476508, 1-22. doi: 10.1155/2015/476508
Ng, Keng Lim, Rajandram, Retnagowri, Morais, Christudas, Yap, Ning Yi, Samaratunga, Hema, Gobe, Glenda C. and Wood, Simon T. (2014). Differentiation of oncocytoma from chromophobe renal cell carcinoma (RCC): Can novel molecular biomarkers help solve an old problem?. Journal of Clinical Pathology, 67 (2), 97-104. doi: 10.1136/jclinpath-2013-201895
Pailoor, Jayalakshmi, Rajandram, Retnagowri, Yap, Ning Yi, Ng, Keng Lim, Wang, Zhiqiang and Iyengar, Krishnan R. (2013). Chromosome 7 aneuploidy in clear cell and papillary renal cell carcinoma: Detection using silver in situ hybridization technique. Indian Journal of Pathology and Microbiology, 56 (2), 98-102. doi: 10.4103/0377-4929.118688
Yap, Ning Yi, Ng, Keng Lim, Ong, Teng Aik, Pailoor, Jayalakshmi, Gobe, Glenda C., Ooi, Chong Chien, Razack, Azad Hassan, Dublin, Norman, Morais, Christudas and Rajandram, Retnagowri (2013). Clinical prognostic factors and survival outcome in renal cell carcinoma patients - a Malaysian single centre perspective. Asian Pacific Journal of Cancer Prevention, 14 (12), 7497-7500. doi: 10.7314/APJCP.2013.14.12.7497
Rajandram, Retnagowri, Bennett, Nigel C., Wang, Zhiqiang, Perry-Keene, Joanna, Vesey, David A., Johnson, David W. and Gobe, Glenda C. (2012). Patient samples of renal cell carcinoma show reduced expression of TRAF1 compared with normal kidney and functional studies in vitro indicate TRAF1 promotes apoptosis: Potential for targeted therapy. Pathology, 44 (5), 453-459. doi: 10.1097/PAT.0b013e3283557748
Rajandram, R., Bennett, N.C., Morais, C., Johnson, D.W. and Gobe, G.C. (2012). Renal cell carcinoma: Resistance to therapy, role of apoptosis, and the prognostic and therapeutic target potential of TRAF proteins. Medical Hypotheses, 78 (2), 330-336. doi: 10.1016/j.mehy.2011.11.014
Conference Papers
Rajandram, R., Owens, E. P., Ellis, R. J., Vecchio, S. J. D., Ong, T. A., Yap, N. Y., Razack, A. H., Wood, S. T. and Gobe, G. C. (2019). Kidney cancer biobanks for research translation in urology. 17th Urological Association of Asia (UAA) Congress, Kuala Lumpur, Malaysia, 7–10 August 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/iju.14061
Yap, N. Y., Ng, K. L., Small, D., Pailoor, J., Ong, T. A., Razack, A., Morais, C., Rajandram, R. and Gobe, G. (2015). NF-KB P65 immunopositivity as an indicator of renal cell carcinoma progression. 24th Malaysian Urological Conference (MUC), Malaysia, Nov 19, 2015. West Sussex, United Kingdom: Wiley-Blackwell.
Yap, N. Y., Ng, K. L., Ong, T. A., Pailoor, J., Razack, A. H. A., Gobe, G., Morais, C. and Rajandram, R. (2014). Clinical data as prognostic tools in the management of renal cell carcinoma (RCC). 67th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Brisbane, QLD, Australia, 16-19 March 2014. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.12619
Yap, N. Y., Rajandram, R., Pailoor, J., Razack, A. H. A., Ong, T. A., Ng, K. L., Morais, C. and Gobe, G. (2013). Evaluating the characteristics of newly diagnosed renal cell carcinoma to improve patient outcome. 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Brisbane, QLD Australia, 9-11 September 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12121
Rajandram, R., Yap, N. Y., Pailoor, J., Razack, A. H. A., Ng, K. L., Gobe, G. and Morais, C. (2013). Molecular Characteristics of Renal Cell Carcinoma - a Study Using Traf-1 and a Malaysian Patient Cohort. 49th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Brisbane, QLD Australia, 9-11 September 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/nep.12121
Vesey, D., Rajandram, R., Blakeney, J., Suen, J., Johnson, D., Fairlie, D. and Gobe, G. (2010). Protease-activated receptor-2 and renal carcinogenesis. 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Perth Convention and Exhibition Centre, Perth, Western Australia, 12-15 September 2010. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2010.01377_1.x
Gobe, Glenda C., Rajandram, Retnagowri, Vesey, David A., Wang, Zhiqiang, Bennett, Nigel and Johnson, David W. (2009). Functional significance of TRAF1 knockdown in renal cell carcinoma anti-cancer treatment. American Society of Nephrology Renal Week: 42nd Annual Meeting & Scientific Exposition, San Diego, CA, U.S.A., 27 October - 1 November, 2009. Washington , D.C., U.S.A.: American Society of Nephrology.
Rajandram, R., Pat, B. K., Percy, C. J., Johnson, D. W. and Gobe, G. C. (2008). Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 5-8 May 2008. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x